1 terminated, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Jay Fournier: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repeated Neurocognitive Measurements in Depressed Patients Intravenous Ketamine - Depression, Unipolar | Phase 1 / Phase 2 | Withdrawn | Jay Fournier | 2025-05-01 | 2026-02-25 | |
| Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study TDCS - transcranial direct current stimulation - Depression, Anxiety | Not applicable | Terminated | Jay Fournier | 4 | 2018-10-01 | 2022-01-04 |
Anxiety Disorders (1) · Depression (1) · Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1)
Ketamine (1) · Transcranial Direct Current Stimulation (1)
United States (2)